You are here

Home » Content

Hypercalcemia of Malignancy Induced by Parathyroid Hormone-related Protein in a Patient with Medullary Thyroid Carcinoma

Paratiroid Hormon İlişkili Proteine Bağlı Malin Hiperkalsemiyle Başvuran Meduller Tiroid Karsinomu Olgusu

Journal Name:

  • İnönü Üniversitesi Tıp Fakültesi Dergisi

Publication Year:

  • 2007

Key Words:

Keywords (Original Language):

Author NameUniversity of AuthorFaculty of Author
Abstract (2. Language): 
We present the case of a 50-year-old male patient presenting with a mass lesion in the neck region and diarrhea. Histological examination of the excisional biopsy specimen revealed medullary thyroid carcinoma. In the laboratory examination of the patient marked hypercalcemia was detected along with a low parathyroid hormone (PTH) levels (<1 pg/ml, (normal range: 10-69 pg/ml). PTH-related protein (PTHrP) level was elevated (8.5 pmol/L, normal range: <1.3 pmol/L). An extensive metastasis screening found metastatic lesions in the liver while no bone metastasis was discovered. The patient died shortly after induction of chemotherapy due to respiratory failure. To the best of our knowledge, this is the first reported case of a PTHrP-producing medullary carcinoma of the thyroid associated with humoral hypercalcemia of malignancy.
Bookmark/Search this post with
Abstract (Original Language): 
Burada boyunda kitle ve diyare ile başvuran 50 yaşında bir erkek hastayı sunduk. Kitleden alınan eksizyonel biopsi örneğinin histolojik incelemesinde meduller tiroid karsinomu saptandı. Gelişindeki laboratuvar tetkiklerinde belirgin hiperkalsemi saptanan hastanın serum paratiroid hormon (PTH) düzeyi <1 pg/ml (normal: 10-69), PTH-ilişkili protein (PTHrP) düzeyi ise 8.5 pmol/L (normal: <1.3) bulundu, ayrıca karaciğerde metastaz saptandı, kemik metastazı tespit edilmedi. Kemoterapi başlanan hastanın durumu progressif olarak kötüleşti ve solunum yetmezliği nedeniyle kaybedildi. Olgumuz literatürde PTHrP üretimine bağlı malign humoral hiperkalseminin nedeni olarak bildirilen ilk meduller tiroid karsinomu olgusudur.
FULL TEXT (PDF): 
PDF icon arastirmax-hypercalcemia-malignancy-induced-parathyroid-hormone-related-protein-patient-medullary-thyroid-carcinoma.pdf
  • 4
263-266
  • Turkish

REFERENCES

References: 

1. Wysolmerski JJ, Broadus AE. Hypercalcemia of malignancy: the central role of
parathyroid hormone-related protein. Annu Rev Med. 1994;45:189-200.
2. Clines GA, Guise TA. Hypercalcemia of malignancy and basic research on
mechanisms responsible for osteolytic and osteoblastic metastasis to bone. Endocr
Relat Cancer 2005;12:549-83.
3. Orlandi F, Caraci P, Mussa A, Saggiorato E, Pancani G, Angeli A. Treatment of
medullary thyroid carcinoma: an update. Endocr Relat Cancer 2001;8:135-47.
4. Barrowman JA, Bennett A, Hillenbrand P, Rolles K, Pollock DJ, Wright JT.
Diarrhoeae in thyroid medullary carcinoma: role of prostaglandins and therapeutic
effect of nutmeg. Br Med J 1975;3:11-2.
5. Smallridge RC, Bourne K, Pearson BW, Van Heerden JA, Carpenter PC, Young WF.
Cushing's syndrome due to medullary thyroid carcinoma: diagnosis by
proopiomelanocortin messenger ribonucleic acid in situ hybridization. J Clin
Endocrinol Metab 2003;88:4565-8.
6. Shuey KM. Hypercalcemia of malignancy: Part I. Clin J Oncol Nurs 2004;8:209-10.
7. Nakashima M, Ohtsuru A, Luo WT, Nakayama T, Enomoto H, Usa T, Kiriyama T,
Ito M, Nagataki S, Yamashita S. Expression of parathyroid hormone-related peptide
in human thyroid tumours. J Pathol 1995;175:227-36.
8. Yazawa S, Toshimori H, Nakatsuru K, Katakami H, Takemura J, Matsukura S.
Thyroid anaplastic carcinoma producing granulocyte-colony-stimulating factor and
parathyroid hormone-related protein Intern Med 1995;34:584-8.
9. Iwai H, Ohno Y, Aoki N. Anaplastic thyroid carcinoma with humoral hypercalcemia
of malignancy (HHM): an autopsy case report. Endocr J 2004;51:303-10.
10. Ito Y, So T, Murayama M, Yasuda K, Miura K, Katakami H. Two cases of papillary
thyroid carcinoma with hypercalcemia and increased serum parathyroid hormonerelated
peptide-like immunoreactivity (PTHrP-LI). Hormone to Rinsho 1993;41:109-
14 (in Japanese).
11. Saito K, Kuratomi Y, Yamamoto K, Saito T, Kuzuya T, Yoshida S, Moriyama SI,
Takahashi A. Primary squamous cell carcinoma of the thyroid associated with marked
leukocytosis and hypercalcemia. Cancer 1981;48:2080-3.
12. Riddle PE, Dincsoy HP. Primary squamous cell carcinoma of the thyroid associated
with leukocytosis and hypercalcemia. Arch Pathol Lab Med 1987;111:373-4.
13. Ikeda K, Weir EC, Mangin M, Dannies PS, Kinder B, Deftos LJ, Brown EM,
Broadus AE. Expression of messenger ribonucleic acids encoding a parathyroid
hormone-like peptide in normal human and animal tissues with abnormal expression
in human parathyroid adenomas. Mol Endocrinol 1988;2:1230-6.
14. Deftos LJ, Gazdar AF, Ikeda K, Broadus AE. The parathyroid hormone-related
protein associated with malignancy is secreted by neuroendocrine tumors. Mol
Endocrinol 1989;3:503-8.
15. Zabel M, Seidel J, Kaczmarek A, Surdyk-Zasada J, Grzeszkowiak J, Gorny A.
Immunocytochemical characterization of two thyroid medullary carcinoma cell lines
in vitro. Histochem J 1995;27:859-68.
16. Welbourn RB. Current status of the apudomas. Ann Surg 1977;185:1-12.
17. Deftos LJ, Parthemore JG. Secretion of parathyroid hormone in patients with
medullary thyroid carcinoma. J Clin Invest 1974;54:416-20.
18. Markovitz M. Medullary carcinoma of the thyroid with hypercalcitoninemia and
hypocalcemia. Ariz Med 1971;28:26-7.
19. Wysolmerski JJ, Vasavada R, Foley J, et al. Transactivation of the PTHrP gene in
squamous carcinomas predicts the occurence of hypercalcemia in athymic mice.
Cancer Res 1996;56:1043-9.

Thank you for copying data from http://www.arastirmax.com